Navigation Links
Florida Hospital collaborates with VTT of Finland
Date:9/18/2013

ORLANDO, Fla., September 18, 2013 In an effort to better understand the development of Alzheimer's disease, Florida Hospital Neuroscience Institute and VTT Technical Research Centre of Finland are collaborating to identify the biomarker assay that may predict early onsets of the disease.

Scientists from VTT and the University of Eastern Finland recently teamed up to discover a serum biochemical signature which predicts progression to Alzheimer's disease. From this, VTT was able to develop a biomarker assay. Florida Hospital and VTT have since come together to evaluate screening, diagnostic and prognostic potential of the biomarker essay.

"Our commitment as a hospital to researching how Alzheimer's disease begins is extremely important for early detection studies and eventually finding a cure for the disease," said Debbie Spielman, AVP Florida Hospital Neuroscience Institute. "Early disease detection can assist in discovering which pharmacological treatment or lifestyle changes would be most beneficial for the patient approaching the early stages of Alzheimer's disease."

According to the Alzheimer's Association, more than 5 million Americans are living with the disease. There are an increasing number of new cases diagnosed annually with increasing aging populations. Florida Hospital and VTT's study will utilize the biomarker assay to harness research on Alzheimer's disease and specifically target which types of precautions to take when approaching early stages of the disease.


'/>"/>

Contact: Matej Orešič
matej.oresic@vtt.fi
358-407-055-156
VTT Technical Research Centre of Finland
Source:Eurekalert

Page: 1

Related biology news :

1. BioClaim, Inc. Signs Biometric Software Contract with Amerigroup Florida
2. Warm springs may be best winter refuge for Florida manatees
3. UF researcher describes new 5-million-year-old saber-toothed cat from Florida
4. Stocking Florida bass in Texas reservoirs may alter stream systems connected to stocked reservoirs
5. Scripps Florida scientist awarded prestigious Javits Neuroscience Investigator Award
6. University of Florida reports 2012 US shark attacks highest since 2000
7. Biocontrol research on Brazilian peppertree in Florida discovers new cryptic species
8. Scripps Florida scientists uncover potential drug target to block cell death in Parkinsons disease
9. Pythons, lionfish and now willow invade Floridas waterways
10. $1 million Kenan Trust Grant extends support of Scripps Florida education outreach
11. One click away: Finding data on Floridas endangered species just got easier
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: